GLOPERBA
Dead / Cancelled — Cancelled — Section 8 (as of 22 Dec 2023)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86871218
- Registration number
- 5219373
- Mark type
- Stylized text
- Filed
- 11 Jan 2016
- Published for opposition
- 03 Jan 2017
- Registered
- 06 Jun 2017
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: Colchicine based pharmaceutical preparations for the prevention of gout flares, recurrent pericarditis, familial Mediterranean fever (FMF), Behcet's disease and long-term atrial fibrillation; Colchicine based pharmaceutical preparations for the treatment of acute gout flares, acute pericarditis, on-going Behcet's disease, familial Mediterranean fever (FMF), and acute atrial fibrillation attack
Owner
- RxOMEG Therapeutics LLC, Woburn, MA, US
- RxOMEG Therapeutics LLC, Woburn, MA, US
- RxOMEG Therapeutics LLC, Woburn, MA, US
Prosecution history
- 22 Dec 2023 — CANCELLED SEC. 8 (6-YR)
- 06 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 05 May 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 23 Mar 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Mar 2017 — USE AMENDMENT FILED
- 15 Mar 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Mar 2017 — TEAS STATEMENT OF USE RECEIVED
- 28 Feb 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jan 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jan 2017 — PUBLISHED FOR OPPOSITION
- 14 Dec 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Nov 2016 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED